Status: Recruiting
The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease
This study is divided into two phases: a dose-escalation phase and an expansion cohort phase. The dose-escalation phase is a single-center study, while the expansion cohort phase is a multicenter, prospective, randomized, double-blind, placebo-controlled study.
Participants needed: 33
Trial details
Phase: Phase 1, Phase 2Age: 50+Biological sex: AllType: InterventionalSponsor: Xuanwu Hospital, BeijingUpdated: May 22, 2026Locations: 1
Eligibility criteria
Age ≥ 50 years, male or female. [+9]
Patients with a known allergic reaction to the investigational drug or similar d... [+15]